Supplemental Financial Information (Tables)

6 Months Ended

Jun. 30, 2026

Other Balance Sheet Details [Abstract]

Inventory consisted of the following:


(in millions)	June 30, 2026		December 31, 2025
Raw materials	$	39.9	$	35.7
Work in process	70.1		19.2
Finished goods	143.3		14.1
Total inventory	253.3		69.0

Balance Sheet Classification:
Inventory	$	104.2	$	69.0
Noncurrent inventory	149.1		—
Total inventory	$	253.3	$	69.0

Schedule of Prepaid Expenses

Prepaid expenses consisted of the following:


(in millions)	June 30, 2026		December 31, 2025
Prepaid income taxes	$	121.8	$	94.0
Prepaid development costs	66.1		55.6
Other prepaid expenses	29.2		21.1
Total prepaid expenses	$	217.1	$	170.7

Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:


(in millions)	June 30, 2026		December 31, 2025
Sales rebates and reserves	$	292.1	$	226.0
Current income taxes payable	114.6		68.0
Accrued development costs	93.5		101.3
Accrued employee related costs	123.2		128.8
Current branded prescription drug fee	42.9		45.3
Accounts payable and other accrued liabilities	142.0		104.9
Total accounts payable and accrued liabilities	$	808.3	$	674.3

Schedule of Other Noncurrent Liabilities

Other noncurrent liabilities consisted of the following:


(in millions)	June 30, 2026		December 31, 2025
Noncurrent income taxes payable	$	262.2	$	214.5
Other noncurrent liabilities	35.5		5.2
Total other noncurrent liabilities	$	297.7	$	219.7

Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows.


(in millions)	June 30, 2026		June 30, 2025
Cash and cash equivalents	$	332.4	$	264.0
Restricted cash included in other noncurrent assets	6.5		8.0
Total cash, cash equivalents, and restricted cash	$	338.9	$	272.0

Schedule of Supplemental Cash Flow Information

The following table presents supplemental cash flow information.


	Six Months Ended June 30,
(in millions)	2026		2025
Cash paid for interest	$	2.7	$	—
Cash paid for income taxes	$	88.2	$	72.5
Accrued capital expenditures	$	1.3	$	1.9
Right-of-use assets acquired through operating leases	$	2.6	$	3.4